Insider activity at Avadel Pharmaceuticals plc has been all selling for a year now: about $233.4 million from one seller, and zero buyers on the open market.
Selling on its own is common and often pre-planned (10b5-1 plans, taxes, diversification), so it matters more when it is unusually heavy or broad.
No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | WEISS ANDREW M | Other | Sell | 11,112,052 | $21.00 | $233.4M | SEC |
| Jan 22, 2025 | Palczuk Linda | Director | Buy | 5,000 | $7.93 | $40K | SEC |
| Jan 14, 2025 | Thornton Peter J. | Director | Buy | 10,000 | $8.05 | $80K | SEC |
| Jan 14, 2025 | Ende Eric J | Director | Buy | 30,000 | $7.84 | $235K | SEC |
| Dec 16, 2024 | MCHUGH THOMAS S | CFO | Buy | 2,300 | $10.44 | $24K | SEC |
| Dec 12, 2024 | MCHUGH THOMAS S | CFO | Buy | 5,000 | $10.49 | $52K | SEC |
| Dec 10, 2024 | Divis Gregory J | CEO | Buy | 402 | $9.82 | $4K | SEC |
| Dec 10, 2024 | Divis Gregory J | CEO | Buy | 9,598 | $9.98 | $96K | SEC |
| Dec 10, 2024 | Glass Geoffrey Michael | Director | Buy | 10,075 | $9.89 | $100K | SEC |
| Dec 10, 2024 | Glass Geoffrey Michael | Director | Buy | 10,204 | $9.80 | $100K | SEC |
| Dec 10, 2024 | Palczuk Linda | Director | Buy | 3,000 | $10.19 | $31K | SEC |
| Jan 16, 2024 | MCHUGH THOMAS S | CFO | Buy | 2,000 | $14.50 | $29K | SEC |
| Dec 29, 2023 | McCamish Mark Anthony | Director | Sell | 75,000 | $14.53 | $1.1M | SEC |
| Aug 15, 2023 | McCamish Mark Anthony | Director | Sell | 28,975 | $14.93 | $433K | SEC |
| Aug 14, 2023 | MCHUGH THOMAS S | CFO | Buy | 2,000 | $14.45 | $29K | SEC |
In the last 12 months Avadel Pharmaceuticals plc insiders made open-market purchases worth about $0 and sales worth about $233.4 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in AVDL was filed on 2026-02-18.
No congressional trades in AVDL were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).